Metabolic
Tirzepatide
Dual GIP / GLP-1 receptor agonist
A synthetic 39-amino-acid peptide engineered as a unimolecular dual agonist at the GIP and GLP-1 receptors. Extensive recent literature in glycemic and metabolic pathway research.
For laboratory research use only. Not for human or animal consumption, not a drug, food, cosmetic, or supplement. By adding to cart, the researcher affirms compliance with all applicable regulations.
Selected research material
Tirzepatide
5mg vial · SKU VRL-TIR-5
Choose vial size
COA record
VRL-TIR-2603
Secure checkout
Waave
Fulfillment
Cold-chain
Research price
$79
RUO only · Lot-matched documentation · Cold-chain handling
Specifications
Tirzepatide is a 39-amino-acid synthetic peptide designed as a balanced agonist at the GIP and GLP-1 receptors, modified with α-aminoisobutyric acid residues and a C20 fatty diacid moiety to confer metabolic stability and albumin binding.
Clinical and preclinical literature across the SURPASS and SURMOUNT program has reported effects on glycemic control, metabolic endpoints, hepatic steatosis, and lipid profiles. The molecule is described extensively in incretin receptor literature.
Supplied as a research-grade reference for investigation of dual incretin receptor pharmacology. Not supplied for human use.
Related research tools
